Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Group A streptococcus

Group A streptococcus

Jan 24, 2013

Meridian Bioscience Reports 13 Percent Spike in Q1 Revenues Driven by Growth in Illumigene Products

Premium

Meridian Bioscience said today that its Illumigene molecular diagnostic products accounted for 16 percent of its fiscal first quarter revenues, which increased 13 percent over the same quarter last year.

Sep 20, 2012

Dx Focus: Roche's CMV Viral Load Test; Meridian's Illumigene Group A Strep Assay

Premium

Roche this week announced the commercial availability of a molecular test for cytomegalovirus viral load.

Sep 17, 2012

FDA Clears Meridian's Group A Streptococcus MDx Test

NEW YORK (GenomeWeb News) – The US Food and Drug Administration has cleared for marketing Meridian Bioscience's Group A Streptococcus molecular diagnostic test that runs on its illumigene platform, the company said after the close of the market on Monday.

Jan 26, 2010

Sequencing Study Reveals Invasive Bacteria Epidemic Patterns

An international research team sequenced and compared almost 100 serotype M3 group A Streptococcus genomes from bugs causing three epidemics in Ontario over more than 15 years.

Pages

The Scan

Breathe It Out

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

The Next Batch

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Switch for the Second

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.

Science Reviews How Non-Genetic DNA Features Expand Utility of Liquid Biopsies, Presents Study of Enzymes in DNA Methylation

In Science this week: review discusses advances in liquid biopsies, and more.

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.